When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
MP3•Episode home
Manage episode 400950650 series 3509339
Content provided by Recruitomics Consulting. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Recruitomics Consulting or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode, we chatted with Stephanie Culler, PhD, Co-Founder and CEO of Persephone Biosciences and part of the Y Combinator 2018 cohort. Persephone is committed to delivering industry-leading technologies for the development of microbiome-targeted therapeutics. We talked about all things poop, as well as strategies to turn a passion for curing human disease into a thriving company.
- Stephanie's favorite book: Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues
- Stephanie's favorite book: Built to Last: Successful Habits of Visionary Companies (Good to Great, Book 2)
- Get Stephanie's favorite book: Good to Great: Why Some Companies Make the Leap...And Others Don't
- Persephone Clinical Studies
- Persephone Biosciences
- Link In with Stephanie!
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
57 episodes